Gene Editing Market Size and Forecasts (2020 – 2030)

Gene Editing Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Component (Reagents and Consumables, Software and Systems, and Services), Technology (Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-Like Effector Nucleases, Zinc Finger Nucleases, and Other Technologies), Application (Genetic Engineering and Clinical Applications), End User (Pharmaceutical companies and Biotechnology Companies, Academics and Government Research Institutes, and Clinical Research Organizations), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)

Send Enquiry
Item ID: TIPRE00032626 Category: Tags: , ,

$3,633$6,433

Description

The gene editing market size is expected to grow from US$ 6.542 billion in 2022 to US$ 23.902 billion by 2030; it is estimated to record a CAGR of 17.6% during 2022-2030.
The growth of the gene editing market is attributed to the increase in cancer and other genetic disorders and growing investment in genetic research. However, the high cost of genomic equipment hinders the market growth.
Personalized medicine is the field that utilizes patients’ genetic and environmental data to deliver optimal healthcare. It is based on the principle that every patient is unique and requires individualistic pharmacological treatment. Since it is a rapidly evolving area, it is presently incorporated into several healthcare systems. The ability to make precise changes in the genome opens new possibilities for developing targeted therapies and personalized medicine. Gene editing is crucial in personalized medicine by tailoring medical treatments to individual patients based on their genetic information. It offers various applications in the field. Firstly, gene editing techniques like CRISPR-Cas9 enable the correction or modification of specific genes associated with genetic disorders, potentially providing treatments or cures for conditions such as cystic fibrosis and other genetic disorders. Secondly, gene editing aids in pharmacogenomics, allowing researchers to study how an individual’s genetic variation impacts their medication response. This knowledge helps in developing personalized treatment plans and optimizing drug dosage.
Gene editing has also shown promise in personalized cancer therapy, where immune cells can be edited to better target and destroy cancer cells. Furthermore, gene editing can contribute to preventing and treating infectious diseases by enhancing immune cell recognition and modifying pathogens. It also facilitates disease modeling and drug development by creating accurate disease models, enabling researchers to understand diseases better and develop personalized treatment approaches. These applications demonstrate the potential of gene editing in advancing personalized medicine, enabling tailored treatments specific to an individual genetic profile. Gene editing in personalized medicine is still advancing, and further research and clinical trials are needed to ensure safety and efficacy.
The growing need for personalized medicine is one of the main factors propelling the growth of the gene editing market. Gene editing technology makes customized therapies and treatments based on an individual’s genetic composition possible. In July 2021, the US FDA authorized one patient to receive a tailored CRISPR-based gene therapy for their mutation. The Boston non-profit Cure Rare Disease initiated the clinical trial, which marked numerous milestones, including the first-ever personalized CRISPR therapy and the first clinical trial to implement any form of gene editing for muscular dystrophy treatment.
Increased patient well-being, fewer adverse effects, and better treatment outcomes are all possible with this personalized approach to medicine. The demand for targeted therapeutics and the increasing understanding of personalized medicine have been major factors in the uptake and development of gene editing technology. The growing number of gene therapy candidates in the development pipeline highlights the potential for transformative breakthroughs in personalized medicine and treating previously incurable diseases, favoring market growth.
The cost of production is determined by the packages of genome editing for different applications offered by different players. The costs associated with gene editing equipment can be substantial. Gene editing technologies like CRISPR-Cas9 require specialized laboratory equipment, including DNA sequencers, thermal cyclers, fluorescence microscopes, and electroporation devices. These instruments have a high price tag, ranging from thousands to millions of dollars. The US Food and Drug Administration (FDA) has authorized four gene treatments. Kymriah and Yescarta are two chimeric antigen receptor (CAR T-cell) treatments. Yescarta costs US$ 373,000 in the market, whereas Kymriah costs between US$ 373,000 and US$ 475,000, depending on the kind of cancer. The FDA licensed Luxturna in 2017 to treat a rare kind of inherited blindness that affects 1,000 to 2,000 people in the US. The cost of this procedure is US$ 425,000 per eye. Zolgensma was licensed in 2020 to treat a rare childhood condition called spinal muscular atrophy in children under the age of two. Per patient, a single intravenous injection costs US$ 2.1 million. The cost of production is increased based on the procedures added during the production.
In addition, additional challenges and costs are associated with the validation and evaluation of genome editing methods. If the validation shows negative results, repetitive procedures are performed, and hundreds and thousands of dollars are spent on the same procedures. Thus, out of the total cost incurred in the production of genome editing, two-thirds is spent on validation. Hence, the cost of production is among the primary factors restraining the market’s growth.
Components-Based Insights
Based on components, the gene editing market is segmented into reagents and consumables, software and systems, and services. The services segment dominated with the largest share of the market in 2022. However, the reagents and consumables segment is anticipated to register the highest CAGR from 2022 to 2030.
The International Agency for Research on Cancer and the World Health Organization (WHO) are among the primary and secondary sources referred to while preparing the gene editing market report.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

In progress

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Middle East & Africa Market Attractiveness
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Live IP Broadcasting Equipment Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Ecosystem Analysis
4.3.1 Raw Material Suppliers:
4.3.2 Manufacturers:
4.3.3 Distributors or Suppliers:
4.3.4 End-Users:
4.3.5 List of Vendors in the Value Chain
5. Middle East & Africa Live IP Broadcasting Equipment Market – Key Industry Dynamics
5.1 Middle East & Africa Live IP Broadcasting Equipment Market – Key Industry Dynamics
5.2 Market Drivers
5.2.1 Advancements in IP Technology
5.2.2 Growth in Media and Entertainment Industry
5.2.3 Surge in Live Gaming and Sports Broadcasting
5.3 Market Restraints
5.3.1 Government-Imposed Rules and Regulations
5.4 Market Opportunities
5.4.1 Growth in 5G Infrastructure and Increasing Adoption of Smart Devices
5.4.2 Technological Advancement and Increasing Demand for Live-Streaming Channels
5.5 Future Trends
5.5.1 Increasing Demand for Live Streaming from Numerous Industries
5.6 Impact of Drivers and Restraints:
6. Middle East & Africa Live IP Broadcasting Equipment Market – Country Market Analysis
6.1 Middle East & Africa Live IP Broadcasting Equipment Market Revenue (US$ Million), 2022 – 2030
6.2 Middle East & Africa Live IP Broadcasting Equipment Market Forecast and Analysis
7. Middle East & Africa Live IP Broadcasting Equipment Market Analysis – Product Type
7.1 Routers and Switches
7.1.1 Overview
7.1.2 Routers and Switches Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Transmitter and Gap Fillers
7.2.1 Overview
7.2.2 Transmitter and Gap Fillers Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Encoders and Converter
7.3.1 Overview
7.3.2 Encoders and Converter Market Revenue and Forecast to 2030 (US$ Million)
7.4 Video Servers
7.4.1 Overview
7.4.2 Video Servers Market Revenue and Forecast to 2030 (US$ Million)
7.5 Antennas
7.5.1 Overview
7.5.2 Antennas Market Revenue and Forecast to 2030 (US$ Million)
7.6 Amplifiers
7.6.1 Overview
7.6.2 Amplifiers Market Revenue and Forecast to 2030 (US$ Million)
7.7 Modulators and Repeaters
7.7.1 Overview
7.7.2 Modulators and Repeaters Market Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others Market Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Live IP Broadcasting Equipment Market Analysis – Application
8.1 Broadcast Production Centers
8.1.1 Overview
8.1.2 Broadcast Production Centers Market Revenue, and Forecast to 2030 (US$ Million)
8.2 Broadcast Stadiums
8.2.1 Overview
8.2.2 Broadcast Stadiums Market Revenue, and Forecast to 2030 (US$ Million)
8.3 Outside Broadcast Vans
8.3.1 Overview
8.3.2 Outside Broadcast Vans Market Revenue, and Forecast to 2030 (US$ Million)
9. Middle East & Africa Live IP Broadcasting Equipment Market – Country Analysis
9.1 Overview
9.1.1 Middle East & Africa Live IP Broadcasting Equipment Market Overview
9.1.2 Middle East & Africa Live IP Broadcasting Equipment Market – Revenue (2022) (US$ Mn)
9.1.3 Middle East & Africa Live IP Broadcasting Equipment Market Revenue and Forecasts and Analysis – By Country
9.1.3.1 Middle East & Africa Live IP Broadcasting Equipment Market Revenue and Forecasts and Analysis – By Country
9.1.3.2 UAE Live IP Broadcasting Equipment Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.3.2.1 UAE Live IP Broadcasting Equipment Market Breakdown by Product Type
9.1.3.2.2 UAE Live IP Broadcasting Equipment Market Breakdown by Application
9.1.3.3 Saudi Arabia Live IP Broadcasting Equipment Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.3.3.1 Saudi Arabia Live IP Broadcasting Equipment Market Breakdown by Product Type
9.1.3.3.2 Saudi Arabia Live IP Broadcasting Equipment Market Breakdown by Application
9.1.3.4 South Africa Live IP Broadcasting Equipment Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.3.4.1 South Africa Live IP Broadcasting Equipment Market Breakdown by Product Type
9.1.3.4.2 South Africa Live IP Broadcasting Equipment Market Breakdown by Application
9.1.3.5 Rest of MEA Live IP Broadcasting Equipment Market Revenue and Forecasts to 2030 (US$ Mn)
9.1.3.5.1 Rest of MEA Live IP Broadcasting Equipment Market Breakdown by Product Type
9.1.3.5.2 Rest of MEA Live IP Broadcasting Equipment Market Breakdown by Application
10. Live IP Broadcasting Equipment Market – Impact of COVID-19 Pandemic
10.1 Pre & Post COVID-19 Impact
11. Middle East & Africa Competitive Landscape
11.1 Middle East & Africa Heat Map Analysis by Key Players
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Product Development
12.4 Mergers & Acquisitions
13. Company Profiles
13.1 Belden Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Cisco Systems Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Evertz Technologies Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 EVS Broadcast Equipment SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sony Group Corp
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Grass Valley Canada
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Harmonic Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Imagine Communications
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 AJA Video Systems Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About
14.2 Word Index

In progress
In progress

The List of Companies – Gene Editing Market
– Thermo Fisher Scientific
– GenScript
– Lonza
– Merck KGaA
– CRISPR Therapeutics
– PerkinElmer Inc.
– Agilent Technologies Inc.
– Precision Biosciences
– Sangamo Therapeutics Inc.
– New England Biolabs
– Novartis

Reviews

There are no reviews yet.

Be the first to review “Gene Editing Market Size and Forecasts (2020 – 2030)”